Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant disease with a very poor prognosis, due to the influence of the tumor stroma, which promotes tumor growth, early invasion and chemoradiation resistance. Efforts to develop models for identifying novel anticancer therapeutic compounds have been hampered by the limited ability of in vitro models to mimic these in vivo tumor-stroma interactions. This has led to the development of various three-dimensional (3D) culture platforms recapitulating the in vivo tumor-stroma crosstalk and designed to better understand basic cancer processes and screen drug action. However, a consensus for different experimental 3D platforms is still missing in PDAC. We compared four PDAC cell lines of diffe...
In tumor engineering, 3D approaches are used to model components of the tumor microenvironment and t...
Pancreatic Ductal Adenocarcinoma (PDAC) is an expeditiously fatal malignancy with a five-year surviv...
Pancreatic ductal adenocarcinoma (PDAC) represents 85-90% of all pancreatic cancers and is the 11th ...
Pancreatic ductal adenocarcinoma (PDAC) is a disease notorious for poor therapeutic response and low...
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment...
Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive type of cancer with an overall su...
Pancreatic cancer carries a terrible prognosis, as the fourth most common cause of cancer death in t...
Pancreatic ductal adenocarcinoma (PDAC) is a challenge for global health with very low survival rate...
In this study we produced 3D organotypic cultures and spheroids to mimic the complex microenvironmen...
AIM:To analyze the effect of three-dimensional (3D)-arrangement on the expression of epithelial-to-m...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies all over the world. T...
Cancer-associated pancreatic stellate cells installed in periacinar/periductal regions are master pl...
Pancreatic Ductal Adenocarcinoma (PDAC) is a fatal neoplasia of the exocrine pancreas with a high mo...
Pancreatic ductal adenocarcinoma (PDAC) is a notoriously lethal disease characterized by prominent s...
Background: Pancreatic ductal adenocarcinoma is a devastating disease with poor outcome, generally c...
In tumor engineering, 3D approaches are used to model components of the tumor microenvironment and t...
Pancreatic Ductal Adenocarcinoma (PDAC) is an expeditiously fatal malignancy with a five-year surviv...
Pancreatic ductal adenocarcinoma (PDAC) represents 85-90% of all pancreatic cancers and is the 11th ...
Pancreatic ductal adenocarcinoma (PDAC) is a disease notorious for poor therapeutic response and low...
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment...
Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive type of cancer with an overall su...
Pancreatic cancer carries a terrible prognosis, as the fourth most common cause of cancer death in t...
Pancreatic ductal adenocarcinoma (PDAC) is a challenge for global health with very low survival rate...
In this study we produced 3D organotypic cultures and spheroids to mimic the complex microenvironmen...
AIM:To analyze the effect of three-dimensional (3D)-arrangement on the expression of epithelial-to-m...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies all over the world. T...
Cancer-associated pancreatic stellate cells installed in periacinar/periductal regions are master pl...
Pancreatic Ductal Adenocarcinoma (PDAC) is a fatal neoplasia of the exocrine pancreas with a high mo...
Pancreatic ductal adenocarcinoma (PDAC) is a notoriously lethal disease characterized by prominent s...
Background: Pancreatic ductal adenocarcinoma is a devastating disease with poor outcome, generally c...
In tumor engineering, 3D approaches are used to model components of the tumor microenvironment and t...
Pancreatic Ductal Adenocarcinoma (PDAC) is an expeditiously fatal malignancy with a five-year surviv...
Pancreatic ductal adenocarcinoma (PDAC) represents 85-90% of all pancreatic cancers and is the 11th ...